Concepedia

Toru Kontani

TK

14

Publications

466

Citations

12

H-Index

1997

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Kagoshima University

Fukushima Medical University

Kyoto University

Toru Kontani is an author at Astellas Pharma (Japan) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1997–2014

14

Publications

14

ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2

Koji Chono, Kiyomitsu Katsumata, Toru Kontani et al. · Journal of Antimicrobial Chemotherapy · 2010 · 158 citations · Full text

Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors

S. Nagashima, Takeshi Hondo, Hiroshi Nagata et al. · Bioorganic & Medicinal Chemistry · 2009 · 47 citations

, , +9

Identification, Synthesis, and Biological Evaluation of 6-[(6<i>R</i>)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-<i>a</i>]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2<i>H</i>)-one (AS1940477), a Potent p38 MAP Kinase Inhibitor

Toru Asano, Hitoshi Yamazaki, Chiyoshi Kasahara et al. · Journal of Medicinal Chemistry · 2012 · 41 citations · Full text

Characterization of virus strains resistant to the herpes virus helicase–primase inhibitor ASP2151 (Amenamevir)

Koji Chono, Kiyomitsu Katsumata, Toru Kontani et al. · Biochemical Pharmacology · 2012 · 33 citations

, , +10

Effect of ASP2151, a Herpesvirus Helicase-Primase Inhibitor, in a Guinea Pig Model of Genital Herpes

Kiyomitsu Katsumata, Koji Chono, Kenji Sudo et al. · Molecules · 2011 · 30 citations · Full text

, , +14

Rows per page

1–5 of 14